BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9873405)

  • 1. Adenosine deaminase inhibitors. Synthesis and biological evaluation of aralkyladenines (ARADS).
    Curtis MA; Varkhedkar V; Pragnacharyulu PV; Abushanab E
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1639-42. PubMed ID: 9873405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine deaminase inhibitors: synthesis and biological evaluation of unsaturated, aromatic, and oxo derivatives of (+)-erythro-9-(2'S-hydroxy-3'R-nonyl)adenine [(+)-EHNA].
    Pragnacharyulu PV; Varkhedkar V; Curtis MA; Chang IF; Abushanab E
    J Med Chem; 2000 Nov; 43(24):4694-700. PubMed ID: 11101360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine deaminase inhibitors. Synthesis of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
    Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S; Lupidi G; Riva F
    J Med Chem; 1984 Mar; 27(3):274-8. PubMed ID: 6699873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based de novo design of non-nucleoside adenosine deaminase inhibitors.
    Terasaka T; Nakanishi I; Nakamura K; Eikyu Y; Kinoshita T; Nishio N; Sato A; Kuno M; Seki N; Sakane K
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1115-8. PubMed ID: 12643924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine deaminase inhibitors. Synthesis and biological evaluation of C1' and nor-C1' derivatives of (+)-erythro-9-(2(S)-hydroxy-3(R)-nonyl)adenine.
    Harriman GC; Poirot AF; Abushanab E; Midgett RM; Stoeckler JD
    J Med Chem; 1992 Oct; 35(22):4180-4. PubMed ID: 1433220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythro- and threo-2-hydroxynonyl substituted 2-phenyladenines and 2-phenyl-8-azaadenines: ligands for A1 adenosine receptors and adenosine deaminase.
    Biagi G; Giorgi I; Livi O; Pacchini F; Rum P; Scartoni V; Costa B; Mazzoni MR; Giusti L
    Farmaco; 2002 Mar; 57(3):221-33. PubMed ID: 11989801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine deaminase inhibitors. Synthesis and biological evaluation of putative metabolites of (+)-erythro-9-(2S-hydroxy-3R-nonyl)adenine.
    Vargeese C; Sarma MS; Pragnacharyulu PV; Abushanab E; Li SY; Stoeckler JD
    J Med Chem; 1994 Oct; 37(22):3844-9. PubMed ID: 7966142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of novel nucleoside and nucleotide analogues as agents against DNA viruses and/or retroviruses.
    Hakimelahi GH; Ly TW; Moosavi-Movahedi AA; Jain ML; Zakerinia M; Davari H; Mei HC; Sambaiah T; Moshfegh AA; Hakimelahi S
    J Med Chem; 2001 Oct; 44(22):3710-20. PubMed ID: 11606136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can adenosine deaminase inhibitors be cytoprotective agents?
    Barankiewicz J; Danks AM; Marangos PJ
    Adv Exp Med Biol; 1998; 431():395-9. PubMed ID: 9598099
    [No Abstract]   [Full Text] [Related]  

  • 10. 9-Benzyladenines: potent and selective cAMP phosphodiesterase inhibitors.
    Bourguignon JJ; Désaubry L; Raboisson P; Wermuth CG; Lugnier C
    J Med Chem; 1997 Jun; 40(12):1768-70. PubMed ID: 9191951
    [No Abstract]   [Full Text] [Related]  

  • 11. Adenosine deaminase inhibitors. Synthesis and biological evaluation of 4-amino-1-(2(S)-hydroxy-3(R)-nonyl)-1H-imidazo[4,5-c]pyridine (3-deaza-(+)-EHNA) and certain C1' derivatives.
    Harriman GC; Abushanab E; Stoeckler JD
    J Med Chem; 1994 Jan; 37(2):305-8. PubMed ID: 8295218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
    Cristalli G; Franchetti P; Grifantini M; Vittori S; Lupidi G; Riva F; Bordoni T; Geroni C; Verini MA
    J Med Chem; 1988 Feb; 31(2):390-3. PubMed ID: 3339608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine deaminase inhibitors: synthesis and structure-activity relationships of imidazole analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
    Cristalli G; Eleuteri A; Franchetti P; Grifantini M; Vittori S; Lupidi G
    J Med Chem; 1991 Mar; 34(3):1187-92. PubMed ID: 2002459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of halogenated 9-(dihydroxycyclopent-4'-enyl) adenines and their inhibitory activities against S-adenosylhomocysteine hydrolase.
    Jeong LS; Park JG; Choi WJ; Moon HR; Lee KM; Kim HO; Kim HD; Chun MW; Park HY; Kim K; Sheen YY
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):919-21. PubMed ID: 14565311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifications of flexible nonyl chain and nucleobase head group of (+)-erythro-9-(2's-hydroxy-3's-nonyl)adenine [(+)-EHNA] as adenosine deaminase inhibitors.
    Kandalkar SR; Ramaiah PA; Joshi M; Wavhal A; Waman Y; Raje AA; Tambe A; Ansari S; De S; Palle VP; Mookhtiar KA; Deshpande AM; Barawkar DA
    Bioorg Med Chem; 2017 Oct; 25(20):5799-5819. PubMed ID: 28951094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine deaminase inhibitors. Conversion of a single chiral synthon into erythro- and threo-9-(2-hydroxy-3-nonyl)adenines.
    Bastian G; Bessodes M; Panzica RP; Abushanab E; Chen SF; Stoeckler JD; Parks RE
    J Med Chem; 1981 Dec; 24(12):1383-5. PubMed ID: 7310814
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimization of the local inhibition of intestinal adenosine deaminase (ADA) by erythro-9-(2-hydroxy-3-nonyl)adenine: enhanced oral delivery of an ADA-activated prodrug for anti-HIV therapy.
    Singhal D; Anderson BD
    J Pharm Sci; 1998 May; 87(5):578-85. PubMed ID: 9572908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does adenosine deaminase inhibition protect ischemic myocardium?
    Gallagher KP; McClanahan TB; Martin BJ; Saganek LJ; Ignasiak DP; Mertz TE; Van Wylen DG; Vinten-Johansen J
    Adv Exp Med Biol; 1994; 370():291-4. PubMed ID: 7660911
    [No Abstract]   [Full Text] [Related]  

  • 19. Adenosine deaminase inhibition enhances the inotropic response mediated by A1 adenosine receptor in hyperthyroid guinea pig atrium.
    Kemeny-Beke A; Jakab A; Zsuga J; Vecsernyes M; Karsai D; Pasztor F; Grenczer M; Szentmiklosi AJ; Berta A; Gesztelyi R
    Pharmacol Res; 2007 Aug; 56(2):124-31. PubMed ID: 17574432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique ring-expanded acyclic nucleoside analogue that inhibits both adenosine deaminase (ADA) and guanine deaminase (GDA; guanase): synthesis and enzyme inhibition studies of 4,6-diamino-8H-1-hydroxyethoxymethyl-8-iminoimidazo[4,5-e][1,3]diazepine.
    Wang L; Hosmane RS
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2893-6. PubMed ID: 11677121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.